UK markets closed

COMPASS Pathways plc (CMPS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
10.73-0.24 (-2.19%)
At close: 04:00PM EDT
11.39 +0.66 (+6.15%)
After hours: 07:22PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close10.97
Open10.89
Bid10.90 x 1000
Ask11.39 x 900
Day's range10.46 - 11.30
52-week range6.54 - 49.51
Volume554,392
Avg. volume381,995
Market cap456.265M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Globe Newswire

    COMPASS Pathways to participate in upcoming Jefferies Innovation in Mental Health Summit

    LONDON, Sept. 19, 2022 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will hold a fireside chat at Jefferies Innovation in Mental Health Summit at 8:30am ET on 22 September 2022. A live audio webcast of the fireside chat will be accessible from the “Events” page of the Investors section of the COMPASS website. Each replay of the webcast wi

  • Globe Newswire

    COMPASS Pathways to participate in three upcoming investor events

    LONDON, Sept. 01, 2022 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will participate in three upcoming investor events as follows: Citi 17th Annual BioPharma Conference: panel at 10:30 am ET on 7 September 2022 and host investor meetingsMorgan Stanley 20th Annual Global Healthcare Conference: fireside chat at 11:45 am ET on 14 September

  • Globe Newswire

    COMPASS Pathways plc announces second quarter 2022 financial results and business highlights

    LONDON, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Highlights: Kabir Nath appointed as Chief Executive Officer Phase III program submitted to FDA and under reviewCOMP360 phase II study in anorexia nervosa launchedCash position at 30 June 2022 of $207.2 millionConference call today at 8:00am ET (1:00pm UK) COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, today reported its financial results